ABSTRACT
INTRODUCTION
Pulmonary artery hypertension is a group of diseases characterized by a growing increase in pulmonary artery pressure that can result in right heart failure and early death (1) . According to Echocardiographic criteria, PAH is defined as mean pulmonary artery pressure (MPAP)≥25 mm at rest (2) . Also, according to CT-scan criteria, MPAD≥29 mm is indicative of PAH (3) . Diagnosis of PH is always a medical dilemma due to its nonspecific clinical manifestations. However, diagnosing PH and determining its severity are essential for the prognosis and treatment planning in PH patients. Pulmonary hypertension (PH) is a significant cause of morbidity and mortality in patients suffering from pulmonary parenchymal disease (4-7). PH diagnostic methods include echocardiography and catheterization of the right heart (8). The latter is the gold standard for diagnosis of PH and the majority of studies show the lower precision of echocardiography compared with right heart catheterization for the diagnosis of PAH. However, echocardiography is a key screening method in the diagnostic algorithm because it has special advantages over invasive procedures. It is safe, portable and repeatable. Therefore, echocardiography is more practical for evaluation of PAH at the beginning of the disease and during the follow up (9) . On the other hand, CT-scan is a more conventional procedure for evaluation of pulmonary diseases especially interstitial lung diseases (ILD) compared to echocardiography (10) (11) (12) .
Although echocardiography is not the gold standard for the diagnosis of PAH, in this study we evaluated the correlation between the definitions of PAH by echocardiography (MPAP≥25 mm) and CTscan (MPAD≥29 mm).
MATERIALS AND METHODS
In a retrospective study, 130 ILD patients presented to Masih Daneshvari Hospital during 2004-2006 who had undergone echocardiography and CTscan at the same time were evaluated in order to find a correlation between pulmonary artery pressure in echocardiography and pulmonary artery diameter in CT-scan. Patients entered the study had interstitial lung disease and had undergone both CT-scan and echocardiography with determination of pulmonary artery pressure with a maximum of 1 month interval between the two. Among these patients, 10 cases had undergone HRCT. However, they were excluded from the study because the mediastinal image was impossible to interpret. CT-scan of 3 patients could not be studied due to motion artifact and these patients were excluded from the study as well. A total of 117 cases were eventually evaluated in this study. Study protocol was approved by the National Research Institute of Tuberculosis and Lung Disease, Masih Daneshvari Hospital. Echocardiography was conducted by the ultrasound device (ATL Ultra Sound, Nr.HDI-3500, USA) and PAP was determined by an expert cardiologist through the backflow of the tricuspid valve. The cardiologist was not aware of the CT-scan result. We defined pulmonary artery hypertension as pulmonary artery pressure over 25mmHg at rest (2). CT-scan was performed by an expert radiologist using the spiral CT-scan single detector device (Siemens, Emotion, Germany) at supine position all over the chest. Pulmonary artery diameter was measured by hand under the supervision of a radiologist in a way that diameter of the main pulmonary artery was measured at the widest part of the artery above its bifurcation. Obtained data were analyzed using SPSS software and p-value, specificity and sensitivity were calculated. A receiver operating characteristic curve (ROC curve) which is indicative of the precision of the diagnostic test was drawn to find the cut off point for the MPAD representing PH. The area under the curve was also calculated in order to define the discriminative power of the test. significantly stronger than that of patients over the age of 50. This association was independent of gender and body surface area (3). In our study, sensitivity and specificity of CT-scan as our diagnostic test of choice for PAH were calculated to be 63% and 41.5%. Also, PAP and PAD in our study had a weak correlation. A major reason for this weak association may be the high mean age (58.96± 17.66) of our study patients. In the above mentioned studies, the diagnostic method of choice was right heart catheterization. However, since this method is not available in the majority of medical centers in our country and also considering its very high cost, we used echocardiography as the alternative method.
Therefore, we cannot make a full comparison between our study results and findings of the aforementioned studies. In other words, we found a weak correlation between PAD in the CT-scan and PAP measured via echocardiography. However, according to some studies echocardiography has fewer efficacies than right heart catheterization as the gold standard for the diagnosis of PAH. In another study, PAP was measured by two methods of echocardiography and right heart catheterization in 374 patients who were lung transplantation candidates and the calculated value was 52% which shows high rate of false positive results for the diagnosis of PAH when using echocardiography (14) . However, some other studies support the critical role of echocardiography in the diagnosis and follow up of PAH (9).
Since echocardiography is not the gold standard method for the diagnosis of PAH, our study results cannot be used as a reference for sensitivity and specificity of CT-scan. But, they can be used for screening purposes for PAH. In order to recommend CT-scan as the screening method for PAH, a similar study needs to be performed using right heart catheterization instead of echocardiography.
